$XXII
22nd Century Group, Inc.

2022 Q1 Form 10-Q Financial Statement

#000155837022007204 Filed on May 05, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q1
Revenue $9.045M $7.960M $6.806M
YoY Change 32.9% 8.92% -3.57%
Cost Of Revenue $8.585M $7.573M $6.159M
YoY Change 39.39% 12.69% -9.04%
Gross Profit $460.0K $387.0K $647.0K
YoY Change -28.9% -34.18% 125.44%
Gross Profit Margin 5.09% 4.86% 9.51%
Selling, General & Admin $7.305M $8.054M $4.829M
YoY Change 51.27% 56.02% 53.74%
% of Gross Profit 1588.04% 2081.14% 746.37%
Research & Development $972.0K $971.0K $701.0K
YoY Change 38.66% -31.13% -26.98%
% of Gross Profit 211.3% 250.9% 108.35%
Depreciation & Amortization $168.0K $316.0K $138.0K
YoY Change 21.74% -9.2% -11.54%
% of Gross Profit 36.52% 81.65% 21.33%
Operating Expenses $8.606M $9.341M $5.818M
YoY Change 47.92% 37.27% 31.36%
Operating Profit -$8.146M -$8.954M -$5.171M
YoY Change 57.53% 43.31% 24.84%
Interest Expense $5.000K -$4.919M $7.000K
YoY Change -28.57% -1348.48% -41.67%
% of Operating Profit
Other Income/Expense, Net -$772.0K $141.0K
YoY Change -647.52% -7.24%
Pretax Income -$8.918M -$13.95M -$5.030M
YoY Change 77.3% 117.85% 26.07%
Income Tax $0.00 $14.00K $0.00
% Of Pretax Income
Net Earnings -$8.918M -$13.97M -$5.030M
YoY Change 77.3% 118.03% 24.84%
Net Earnings / Revenue -98.6% -175.44% -73.91%
Basic Earnings Per Share -$0.05 -$0.03 -$0.03
Diluted Earnings Per Share -$0.05 -$85.76K -$0.03
COMMON SHARES
Basic Shares Outstanding 163.2M 162.7M 144.3M
Diluted Shares Outstanding 163.2M 144.3M

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $38.62M $48.74M $30.94M
YoY Change 24.81% 118.14% -8.97%
Cash & Equivalents $1.584M $1.336M $1.272M
Short-Term Investments $37.04M $47.40M $29.67M
Other Short-Term Assets $1.389M $2.183M $1.280M
YoY Change 8.52% 20.87% 38.83%
Inventory $3.753M $2.881M $2.137M
Prepaid Expenses
Receivables $1.220M $585.0K $2.023M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $44.98M $54.39M $36.38M
YoY Change 23.63% 91.9% -5.49%
LONG-TERM ASSETS
Property, Plant & Equipment $5.949M $5.841M $2.669M
YoY Change 122.89% 135.24% -27.88%
Goodwill $0.00
YoY Change
Intangibles $7.934M $7.919M $8.110M
YoY Change -2.17% -3.56%
Long-Term Investments $2.211M $2.345M $6.643M
YoY Change -66.72% -64.12% -17.95%
Other Assets $3.770M $3.741M
YoY Change -36.33%
Total Long-Term Assets $21.50M $21.57M $23.30M
YoY Change -7.74% -7.64% -10.29%
TOTAL ASSETS
Total Short-Term Assets $44.98M $54.39M $36.38M
Total Long-Term Assets $21.50M $21.57M $23.30M
Total Assets $66.48M $75.95M $59.68M
YoY Change 11.39% 46.93% -7.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.512M $2.173M $1.572M
YoY Change -3.82% 94.71% 8.71%
Accrued Expenses $2.227M $1.489M $4.681M
YoY Change -52.42% 59.94% 59.71%
Deferred Revenue $483.0K $119.0K $0.00
YoY Change -56.25%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $596.0K $295.0K
YoY Change -100.0% 10.58% -49.74%
Total Short-Term Liabilities $7.182M $8.427M $7.004M
YoY Change 2.54% 14.76% 39.11%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $1.326M $21.00K $187.0K
YoY Change 609.09% -91.29% -77.42%
Total Long-Term Liabilities $1.326M $21.00K $187.0K
YoY Change 609.09% -91.29% -83.3%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.182M $8.427M $7.004M
Total Long-Term Liabilities $1.326M $21.00K $187.0K
Total Liabilities $8.508M $9.880M $7.191M
YoY Change 18.31% 30.27% 16.83%
SHAREHOLDERS EQUITY
Retained Earnings -$186.9M -$178.0M -$150.4M
YoY Change 24.26% 22.43%
Common Stock $2.000K $2.000K $2.000K
YoY Change 0.0% 100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $57.97M $66.07M $52.49M
YoY Change
Total Liabilities & Shareholders Equity $66.48M $75.95M $59.68M
YoY Change 11.39% 46.93% -7.42%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q1
OPERATING ACTIVITIES
Net Income -$8.918M -$13.97M -$5.030M
YoY Change 77.3% 118.03% 24.84%
Depreciation, Depletion And Amortization $168.0K $316.0K $138.0K
YoY Change 21.74% -9.2% -11.54%
Cash From Operating Activities -$7.928M -$4.632M -$3.911M
YoY Change 102.71% 54.55% -16.11%
INVESTING ACTIVITIES
Capital Expenditures $258.0K -$362.0K $100.0K
YoY Change 158.0% 146.26% -190.09%
Acquisitions
YoY Change
Other Investing Activities $9.135M $5.840M -$8.415M
YoY Change -208.56% 51.26% -268.06%
Cash From Investing Activities $8.772M $5.478M -$8.535M
YoY Change -202.78% 47.5% -274.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -596.0K -1.139M 12.69M
YoY Change -104.7% -7.4%
NET CHANGE
Cash From Operating Activities -7.928M -4.632M -3.911M
Cash From Investing Activities 8.772M 5.478M -8.535M
Cash From Financing Activities -596.0K -1.139M 12.69M
Net Change In Cash 248.0K -293.0K 243.0K
YoY Change 2.06% -42.88% 3.85%
FREE CASH FLOW
Cash From Operating Activities -$7.928M -$4.632M -$3.911M
Capital Expenditures $258.0K -$362.0K $100.0K
Free Cash Flow -$8.186M -$4.270M -$4.011M
YoY Change 104.09% 49.82% -11.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 xxii Property Plant And Equipment Additions Included In Accounts Payable
PropertyPlantAndEquipmentAdditionsIncludedInAccountsPayable
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
163157000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144258000
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001347858
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
163157000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144258000
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7919000
CY2022Q1 us-gaap Long Term Investments
LongTermInvestments
2211000
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
2345000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3770000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3741000
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019 xxii Postemployment Benefit Period
PostemploymentBenefitPeriod
P42M
CY2021Q2 xxii Directors And Officers Insurance Policy Term
DirectorsAndOfficersInsurancePolicyTerm
P1Y
CY2021Q2 us-gaap Debt Instrument Term
DebtInstrumentTerm
P9M
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
164536566
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
162872875
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-36338
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
22nd Century Group, Inc.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0468420
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
500 Seneca Street
CY2022Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 507
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Buffalo
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
14204
CY2022Q1 dei City Area Code
CityAreaCode
716
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
270-1523
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.00001 par value
CY2022Q1 dei Trading Symbol
TradingSymbol
XXII
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
164536566
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1584000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1336000
CY2022Q1 us-gaap Short Term Investments
ShortTermInvestments
37036000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
47400000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1220000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
585000
CY2022Q1 us-gaap Inventory Net
InventoryNet
3753000
CY2021Q4 us-gaap Inventory Net
InventoryNet
2881000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1389000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2183000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
44982000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
54385000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5949000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5841000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1631000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1723000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7934000
CY2022Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
161000
CY2022Q1 us-gaap Assets
Assets
66477000
CY2021Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
6159000
CY2022Q1 xxii Gross Profit Excluding Depreciation
GrossProfitExcludingDepreciation
460000
CY2021Q1 xxii Gross Profit Excluding Depreciation
GrossProfitExcludingDepreciation
647000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7305000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4829000
CY2022Q1 us-gaap Depreciation
Depreciation
168000
CY2021Q4 us-gaap Assets
Assets
75954000
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
596000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
359000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
308000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1512000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2173000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2227000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1489000
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
405000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2255000
CY2022Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
2009000
CY2021Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1270000
CY2022Q1 us-gaap Postemployment Benefits Liability Current
PostemploymentBenefitsLiabilityCurrent
187000
CY2021Q4 us-gaap Postemployment Benefits Liability Current
PostemploymentBenefitsLiabilityCurrent
217000
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
483000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
119000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
7182000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8427000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1326000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1432000
CY2021Q4 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
21000
CY2022Q1 us-gaap Liabilities
Liabilities
8508000
CY2021Q4 us-gaap Liabilities
Liabilities
9880000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
164536566
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
162872875
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
2000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
245460000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
244247000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-562000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-162000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-186931000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-178013000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
57969000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
66074000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
66477000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
75954000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9045000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6806000
CY2022Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
8585000
CY2021Q1 us-gaap Depreciation
Depreciation
138000
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
65000
CY2021Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
150000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
8606000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
5818000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8146000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5171000
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-817000
CY2021Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
36000
CY2022Q1 us-gaap Investment Income Net
InvestmentIncomeNet
50000
CY2021Q1 us-gaap Investment Income Net
InvestmentIncomeNet
112000
CY2022Q1 us-gaap Interest Expense
InterestExpense
5000
CY2021Q1 us-gaap Interest Expense
InterestExpense
7000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-772000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
141000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8918000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5030000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-8918000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5030000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-400000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-32000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-400000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-32000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9318000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5062000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
163157000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144258000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
66074000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1213000
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-400000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-8918000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
57969000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
44110000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1153000
CY2021Q1 xxii Stock Issued During Period Value Warrants Exercise
StockIssuedDuringPeriodValueWarrantsExercise
11782000
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
507000
CY2021Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-32000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5030000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
52490000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-8918000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-5030000
CY2022Q1 xxii Amortization And Depreciation Excluding Amortization Of Intangibles
AmortizationAndDepreciationExcludingAmortizationOfIntangibles
267000
CY2021Q1 xxii Amortization And Depreciation Excluding Amortization Of Intangibles
AmortizationAndDepreciationExcludingAmortizationOfIntangibles
226000
CY2022Q1 xxii Amortization Of License Fees
AmortizationOfLicenseFees
62000
CY2021Q1 xxii Amortization Of License Fees
AmortizationOfLicenseFees
62000
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
92000
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-817000
CY2021Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
36000
CY2022Q1 xxii Accretion Income
AccretionIncome
-119000
CY2021Q1 xxii Accretion Income
AccretionIncome
39000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
3000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
1000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1213000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
507000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
635000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-135000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
872000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
103000
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-794000
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-526000
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-55000
CY2021Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-66000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-661000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
381000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
647000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-196000
CY2022Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1850000
CY2021Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
214000
CY2022Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
739000
CY2021Q1 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
-166000
CY2022Q1 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-51000
CY2021Q1 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-119000
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
364000
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-272000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7928000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3911000
CY2022Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
105000
CY2021Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
20000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
258000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
100000
CY2022Q1 xxii Payments To Acquire Investment Including Receivable And Equity Securities
PaymentsToAcquireInvestmentIncludingReceivableAndEquitySecurities
682000
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment
ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment
13595000
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment
ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment
4950000
CY2022Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
3778000
CY2021Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
13365000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8772000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8535000
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
596000
CY2021Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
246000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1153000
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
11782000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-596000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12689000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
248000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
243000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1336000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1029000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1584000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1272000
CY2021Q1 xxii Patent And Trademark Additions Included In Accounts Payable
PatentAndTrademarkAdditionsIncludedInAccountsPayable
29000
CY2021Q1 xxii Property Plant And Equipment Additions Included In Accounts Payable
PropertyPlantAndEquipmentAdditionsIncludedInAccountsPayable
43000
CY2022Q1 xxii Property Plant And Equipment Additions Included In Accrued Expenses
PropertyPlantAndEquipmentAdditionsIncludedInAccruedExpenses
18000
CY2022Q1 xxii Patent And Trademark Additions Included In Accrued Liabilities Current
PatentAndTrademarkAdditionsIncludedInAccruedLiabilitiesCurrent
73000
CY2022Q1 xxii Number Of Subsidiaries
NumberOfSubsidiaries
5
CY2022Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Reclassifications</span> – Certain prior period amounts have been reclassified to conform to the current period’s classification. None of these reclassifications had a material impact on our consolidated financial statements.</p>
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span><i style="font-style:italic;"> </i><b style="font-weight:bold;">-</b><i style="font-style:italic;"> </i>The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2022Q1 xxii Inventory Tobacco Leaf Gross
InventoryTobaccoLeafGross
2003000
CY2021Q4 xxii Inventory Tobacco Leaf Gross
InventoryTobaccoLeafGross
1352000
CY2022Q1 xxii Inventory Hemp Cannabis Gross
InventoryHempCannabisGross
113000
CY2021Q4 xxii Inventory Hemp Cannabis Gross
InventoryHempCannabisGross
10000
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
267000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
256000
CY2022Q1 xxii Inventory Raw Materials Excluding Tobacco Leaf
InventoryRawMaterialsExcludingTobaccoLeaf
1470000
CY2021Q4 xxii Inventory Raw Materials Excluding Tobacco Leaf
InventoryRawMaterialsExcludingTobaccoLeaf
1363000
CY2022Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
100000
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
100000
CY2022Q1 us-gaap Inventory Net
InventoryNet
3753000
CY2021Q4 us-gaap Inventory Net
InventoryNet
2881000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3468000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3300000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5949000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5841000
CY2022Q1 us-gaap Depreciation
Depreciation
168000
CY2021Q1 us-gaap Depreciation
Depreciation
138000
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y3M18D
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.033
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
304000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
429000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
448000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
418000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
111000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
108000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1818000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
133000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1685000
CY2022Q1 us-gaap Long Term Investments
LongTermInvestments
2211000
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
2345000
CY2022Q1 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
3770000
CY2021Q4 us-gaap Notes Receivable Related Parties Noncurrent
NotesReceivableRelatedPartiesNoncurrent
3741000
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
5000
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
683000
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
15508000
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
15339000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
8286000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
8280000
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
20033000
CY2022Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
19639000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
30357000
CY2021Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
30201000
CY2022Q1 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
35541000
CY2022Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
34978000
CY2021Q4 us-gaap Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss
38643000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
38481000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7934000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7919000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
161000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
150000
CY2021Q2 xxii Directors And Officers Insurance Premium
DirectorsAndOfficersInsurancePremium
3315000
CY2021Q2 xxii Directors And Officers Insurance Premium Paid
DirectorsAndOfficersInsurancePremiumPaid
662000
CY2021Q2 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2653000
CY2021Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0349
CY2021Q4 xxii Directors And Officers Insurance Payable Current
DirectorsAndOfficersInsurancePayableCurrent
596000
CY2020Q2 us-gaap Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
306000
CY2020Q2 xxii Postemployment Benefit Period
PostemploymentBenefitPeriod
P12M
CY2019 us-gaap Postemployment Benefits Period Expense
PostemploymentBenefitsPeriodExpense
881000
CY2019Q4 us-gaap Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
771000
CY2022Q1 us-gaap Postemployment Benefits Liability Current
PostemploymentBenefitsLiabilityCurrent
187000
CY2022Q1 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
0
CY2021Q4 us-gaap Postemployment Benefits Liability Current
PostemploymentBenefitsLiabilityCurrent
217000
CY2021Q4 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
21000
CY2021Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10000000
CY2021Q2 us-gaap Share Price
SharePrice
4.00
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
38206000
CY2021Q1 xxii Number Of Warrants Exercised
NumberOfWarrantsExercised
11293211
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
11782000
CY2022Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0
CY2022Q1 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
3260000
CY2022Q1 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
3445000
CY2022Q1 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
3350000
CY2022Q1 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
1524000
CY2022Q1 xxii Contractual Obligation Due After Fourth Year
ContractualObligationDueAfterFourthYear
2730000
CY2022Q1 us-gaap Contractual Obligation
ContractualObligation
14309000
CY2019Q4 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
3
CY2020Q1 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
3
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
5000000
CY2022Q1 xxii Share Based Compensation Arrangement Plan Term
ShareBasedCompensationArrangementPlanTerm
P10Y
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
4990653
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3165000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.50
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
2607000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.19
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1664000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
2.39
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
71000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
2.40
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
4037000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.35
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
3800000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5171000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.65
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5171000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.65
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y4M24D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4107000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5014000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.62
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y3M18D
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
4107000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0054
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8792
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y1M2D
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1213000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
507000
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
8855000
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y6M
CY2022Q1 xxii Employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptionswithmilestonebasedvesting
Employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptionswithmilestonebasedvesting
682000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2022Q1 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
2719000
CY2021Q1 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
2063000
CY2022Q1 xxii Contract Asset Payment Period After Shipment
ContractAssetPaymentPeriodAfterShipment
P21D
CY2022Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
213000
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
178000
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
483000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
119000
CY2022Q1 xxii Contract Asset Liability Net
ContractAssetLiabilityNet
-270000
CY2021Q4 xxii Contract Asset Liability Net
ContractAssetLiabilityNet
59000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9045000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6806000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-8918000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5030000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
163157000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
144258000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9208000
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9447000

Files In Submission

Name View Source Status
0001558370-22-007204-index-headers.html Edgar Link pending
0001558370-22-007204-index.html Edgar Link pending
0001558370-22-007204.txt Edgar Link pending
0001558370-22-007204-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xxii-20220331.xsd Edgar Link pending
xxii-20220331x10q.htm Edgar Link pending
xxii-20220331x10q_htm.xml Edgar Link completed
xxii-20220331xex31d1.htm Edgar Link pending
xxii-20220331xex31d2.htm Edgar Link pending
xxii-20220331xex32d1.htm Edgar Link pending
xxii-20220331_cal.xml Edgar Link unprocessable
xxii-20220331_def.xml Edgar Link unprocessable
xxii-20220331_lab.xml Edgar Link unprocessable
xxii-20220331_pre.xml Edgar Link unprocessable